Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
STATEMENT OF PURPOSE AND POLICY
Diabetes Technology & Therapeutics will accept original papers and reviews about the use of technology and products to treat, diagnose, and prevent diabetes. Manuscripts submitted to Diabetes Technology & Therapeutics must not contain material that has been reported elsewhere (except in the form of an abstract published for a scientific meeting) or be under consideration for publication elsewhere. Prior abstracts should be described in a footnote to the title.
Diabetes Technology & Therapeutics is a rapid publication journal. Articles are published online ahead of print in 3-4 weeks.
PLEASE READ ALL THE INSTRUCTIONS TO AUTHORS BEFORE SUBMITTING.
All manuscripts must be submitted online at http://mc.manuscriptcentral.com/diabetestechnology
Liebert Instant Online (LION) -- Effective June 1, 2017
To enable the release of new scientific findings as quickly as possible, as of June 1, 2017 the Journal pre-publishes all accepted manuscripts in their unedited format upon submission of all authors' copyright forms. The papers will have undergone full peer review but will not have been copyedited, typeset, or proofread by the authors. It is anticipated that all our authors are excited to take advantage of this accelerated publication service. All accepted papers for which all copyright forms have been returned will appear online as a part of Liebert Instant Online (LION) within 72 hours of the completion of all copyright forms.
Following its publication on the LION platform, the paper will progress through the customary production processes, including copyediting and author corrections to galley proofs and online publication of the final edited and typeset manuscript ahead of print.
It is essential to note that, as part of the LION program, the data that is published on the LION platform is pulled directly from the information that was populated into the fields in Manuscript Central upon submission not as listed in the manuscript Word document. Consequently, any errors contained in the system will remain on our website and all indexing services, including Medline/PubMed, until the next revision of the article is published. It is therefore critically important to properly enter all authors' names, affiliations, and email addresses of all authors under the "my authors" section when uploading your manuscript. This author list is what will be used for the Journal’s LION program and its initial listing on PubMed. No errors appearing on our website, or in any indexing service, can be corrected until the subsequent revision is published.
The next revision will take place after the corresponding author reviews the page proofs, makes any necessary corrections, and returns the changes to the Publisher. Once all alterations are made, the revised version will be published on our website, and the newly corrected information will be released to Medline/PubMed, in addition to any other indexing services in which the Journal is included.
The typical time between acceptance of a paper and page proof distribution is approximately 4-8 weeks depending on the length and complexity of the paper.
PREPARATION OF MANUSCRIPT
Prepare manuscripts double-spaced. Leave ample margins on both sides, top and bottom.
Word limits are as follows:
- Original paper: 5000 words
- Invited paper or review articles: 6000 words with no more than 2-3 tables or figures.
- Brief reports: 1500-2000 words, plus 1 table and 1 figure.
- Invited editorials: 1,500 words, with no more than 1 table or figure, and up to 30 references.
A title page should be part of your main text file and should include all authors’ names and affiliations, the funding source (if appropriate), and a running title of up to 45 characters. Please indicate the name, address, phone number, fax number, and e-mail addressof the author to whom reprint requests should be addressed.
Manuscript keywords (search terms): On the title page of the manuscript, include a minimum of three (3), maximum of six (6), search terms that will aid in the discoverability of the article in indexing services and search engines. These terms may or may not be different from the terms you selected for the peer review process and areas of expertise. You will be asked to retype these search terms in the submission form when uploading your manuscript. These keywords will be included in the published article. If the search terms entered do not match the manuscript, the manuscript will serve as the default.
Keywords (Areas of Expertise)
To facilitate the peer review process, select a minumum of five (5) keywords from the drop-down list of pre-selected terms when submitting your manuscript. These keywords will assist in the selection of skilled reviewers in the field for the purposes of peer review.
The abstract should be no more than 250 words. Abstracts of original papers should contain four paragraphs labeled as: Background, Methods, Results, and Conclusions. Abstracts of reviews should contain a single unlabeled paragraph.
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.”
In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision.
Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance.
If no conflicts exist, the authors must state “No competing financial interests exist.
TABLES AND ILLUSTRATIONS
Tables should be prepared in Word and be supplied in a separate file from the text. Use Arabic numerals to number tables. Each table must stand alone, i.e., contain all necessary information in the caption, and the table itself must be understood independently of the text. Details of experimental conditions should be included in the table footnotes. Information that appears in the text should not be repeated in the table, and tables should not contain data that can be given in the text in one or two sentences. Each supplied table must have a title.
Please submit artwork according to the following guidelines:
• Do NOT embed art files into a Word or PDF document.
• Line illustrations should be submitted at 900 dpi.
• Halftones and color should be submitted at a minimum of 300 dpi.
• Save as either TIFF or EPS files.
• Color art must be saved as CYMK - not RGB.
• Black and White art must be submitted as grayscale – not RGB.
• Do NOT submit PowerPoint, PDF, Bitmap or Excel files.
• Do NOT include the figure legend as part of the figure file. All figure legends should be prepared in one separate Word document and uploaded under the "Figure Legends" file category.
Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc. Authors who do not follow these guidelines may have their submission returned to them without being reviewed.
ADDITIONAL INFORMATION ABOUT ART FILES
Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
• All files should be scanned at 100% size.
• 300 dpi
• Final color mode: cmyk
• save file as: .tif or .eps
If you need directions on how to convert a Power Point slide to acceptable format go to https://home.liebertpub.com/MEDIA/pdf/ppconvert.pdf
All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section.
List references in consecutive numerical order (not alphabetically). All subsequent reference citations should be to the original number. Cite all references in the text or tables. Unpublished data and personal communications should not be listed as references. Abbreviations of journal titles should follow MEDLINE.
References to journal papers should include: (1) author(s) (list the first three authors, followed by et al. if applicable), (2) title, (3) journal name (as abbreviated in MEDLINE), (4) year, (5) volume number, and 6) inclusive page numbers, in that order.
References to books should include: (1) author(s), (2) chapter title (if any), (3) editor (if any), (4) title of book, (5) city of publication, (6) publisher, and (7) year. Volume and edition numbers, specific pages, and name of translator should be included when appropriate. The author is responsible for the accuracy and completeness of the references and for their correct text citation.
It is the submitting author’s responsibility to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. Once a paper is accepted for publication, changes in authorship while the paper is in production – including page proofs – are NOT permitted. Changes in authorship after publication are strictly prohibited.
PATIENT RELEASE INFORMATION
If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients. The submitting author should provide written confirmation of this critical information. Acceptable forms of consent statements are emails or letters. The Journal does not provide a generic patient release form.
The written consent must contain specific information about the patient's name, age, and if pertinent, conservatorship -- as well as stated permission -- granting the Journal the rights to publish the photograph within its pages (which includes the name of the Journal and article title).
Submission fee Not applicable
Page charges Not applicable
Color printing Optional (Contact AuthorServices@liebertpub.com for price quote)
Open Option $3200.00 USD Optional (Contact OpenAccess@liebertpub.com for details)
Reprints* Email: Reprints@liebertpub.com for pricing (optional)
The author must obtain permission to reproduce figures, tables and text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure or legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material and should accompany the manuscript.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: 914-740-2100; fax: 914-740-2101. E-mail: email@example.com Online: www.liebertpub.com
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.org.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.